Primary and secondary endpoints in clinical trials.
Jacobsen
Lars
L
Allergy Learning and Consulting, Smørum, Copenhagen.
D000485:Allergens / Q000627:therapeutic use*; D002986:Clinical Trials as Topic / Q000706:statistics & numerical data*; D003888:Desensitization, Immunologic / Q000706:statistics & numerical data; D023381:Endpoint Determination / Q000706:statistics & numerical data; D006801:Humans; D017410:Practice Guidelines as Topic
D000485:Allergens